I Ask This Of You!

I have Parkinson's diseases and thought it would be nice to have a place where the contents of updated news is found in one place. That is why I began this blog.

I copy news articles pertaining to research, news and information for Parkinson's disease, Dementia, the Brain, Depression and Parkinson's with Dystonia. I also post about Fundraising for Parkinson's disease and events. I try to be up-to-date as possible.

I am not responsible for it's contents. I am just a copier of information searched on the computer. Please understand the copies are just that, copies and at times, I am unable to enlarge the wording or keep it uniformed as I wish.

This is for you to read and to always keep an open mind.

Please discuss this with your doctor, should you have any questions, or concerns.

Never do anything without talking to your doctor. I do not make any money from this website. I volunteer my time to help all of us to be informed. I will not accept any information about Herbal treatments curing Parkinson's, dementia and etc. It will go into Spam.

This is a free site for all with no advertisements.

Thank you for visiting!

Saturday, May 27, 2017

FoxFeed Blog A Note from Our CEO: Research in a Time of Uncertainty

Todd Sherer, PhD
Editor's Note: For more Foundation news, research updates and tips on living well with Parkinson's, read the Spring/Summer 2017 edition of The Fox Focus, our biannual newsletter. 
Parkinson's disease (PD) research stands at a critical juncture. The state of the science continues to advance, demonstrating growing promise for the millions worldwide living with the disease. The impact of The Michael J. Fox Foundation is increasingly felt in the field, stemming from our multi-million-dollar efforts to speed drug development by fostering data sharing, supporting discovery research, and driving biomarker validation. Today, we not only direct funds to individual disease-modifying and symptomatic therapies, but also establish frameworks and tools that will accelerate all projects in their pursuit of breakthroughs.
We have never been in a position to do this alone. Perhaps the only thing about PD research that has remained constant over two centuries is that it requires strategic risk-taking, enterprise and collaboration. In our short history, we have become a unique stakeholder building mutually beneficial relationships with both academic and industry researchers. We identify promising findings from basic research and infuse them with the resources required to move forward, forging consortia and collaborations that bring key players into Parkinson's research. These efforts, often through partnerships with the National Institutes of Health (NIH) and private industry, have resulted in numerous potential therapies currently in development, which you'll read about in this newsletter.
But we are living in uncertain times. While the NIH recently secured an additional $2 billion through September, there are no guarantees around federal funding for research in 2018 and beyond. In The New York Times, former NIH director Harold Varmus writes: "A substantial NIH budget cut would...diminish opportunities to discover new ways to prevent and treat diseases."
Yet the challenge lies not only in government funding cuts; the private sector, too, is increasingly risk-averse, especially in neuroscience, where late-stage clinical testing is astronomically expensive with no guarantee of success.
Given these realities, now more than ever our Foundation is deeply grateful for your support. We will continue using your contributions as quickly and wisely as possible to support new discovery, vital translational research and innovative scientists who have devoted their lives to finding better treatments and a cure for PD. We're proud of our track record of efficiency, with 89 cents of every dollar we spend going straight to our programs. And we count on you to stay with us as we drive toward a future where Parkinson's is in the rearview mirror.
P.S. We're staying ahead of action in Washington, D.C. that's significant for the PD community on our blog at

No comments:

Post a Comment